Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387015877> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4387015877 endingPage "AB183" @default.
- W4387015877 startingPage "AB183" @default.
- W4387015877 abstract "Background: Atopic dermatitis (AD) affects up to 20% of children worldwide (1). Approved treatments include phosphodiesterase-4 (PDE-4) inhibitors, topical calcineurin inhibitors (TCI), and topical corticosteroids (TCS), but TCS-related side effects can limit their use (2,3,4). This study investigated efficacy of PDE-4 inhibitors in reducing TCS usage and improving quality of life (QOL) in pediatric AD patients. Patients aged 2-17 with mild or moderate AD were recruited from the Johns Hopkins Pediatric Dermatology Department and blindly randomized to use PDE-4 inhibitor, vehicle, or control ointment. Patients using TCI performed a two-week washout period prior to enrollment. Participants were evaluated at study onset, after 30 days, and after 90 days, through photographs, AD scoring, and pruritus rating (5,6). QOL was surveyed using QOL indices (CDLQI/DLQI) and family impact questionnaires (DFI) (7,8,9). Fourteen patients were enrolled, and preliminary data was collected from ten patients (mean age 7.5 years). Preliminary results demonstrate average decrease in DFI of 4.6 points in PDE-4 inhibitor group compared to 1 point in vehicle/control group. QOL indexes demonstrate average 4.7 point improvement in PDE-4 group compared to 1.5 points in vehicle/control group. AD scoring decreased in vehicle/control groups by 5.26 points, and in PDE-4 inhibitor groups by 1.27 points. Overall, patients using PDE-4 inhibitor used TCS an average 1.3 times weekly vs. 2.1 times in vehicle/control group. Our analyses demonstrate efficacy of PDE-4 inhibitors in decreasing TCS use in pediatric patients. These findings are important in guiding management of AD patients to minimize the potential impact of TCS- related adverse effects." @default.
- W4387015877 created "2023-09-26" @default.
- W4387015877 creator A5016516842 @default.
- W4387015877 creator A5021580006 @default.
- W4387015877 creator A5070859678 @default.
- W4387015877 creator A5084198628 @default.
- W4387015877 date "2023-09-01" @default.
- W4387015877 modified "2023-09-26" @default.
- W4387015877 title "41385 Investigating efficacy of PDE-4 inhibitors in reducing topical steroid use for management of pediatric atopic dermatitis: A double-blind randomized control study" @default.
- W4387015877 doi "https://doi.org/10.1016/j.jaad.2023.07.733" @default.
- W4387015877 hasPublicationYear "2023" @default.
- W4387015877 type Work @default.
- W4387015877 citedByCount "0" @default.
- W4387015877 crossrefType "journal-article" @default.
- W4387015877 hasAuthorship W4387015877A5016516842 @default.
- W4387015877 hasAuthorship W4387015877A5021580006 @default.
- W4387015877 hasAuthorship W4387015877A5070859678 @default.
- W4387015877 hasAuthorship W4387015877A5084198628 @default.
- W4387015877 hasConcept C126322002 @default.
- W4387015877 hasConcept C159110408 @default.
- W4387015877 hasConcept C16005928 @default.
- W4387015877 hasConcept C168563851 @default.
- W4387015877 hasConcept C2776173921 @default.
- W4387015877 hasConcept C2777520566 @default.
- W4387015877 hasConcept C2778329239 @default.
- W4387015877 hasConcept C2779134260 @default.
- W4387015877 hasConcept C2779951463 @default.
- W4387015877 hasConcept C2780699399 @default.
- W4387015877 hasConcept C71924100 @default.
- W4387015877 hasConcept C90924648 @default.
- W4387015877 hasConceptScore W4387015877C126322002 @default.
- W4387015877 hasConceptScore W4387015877C159110408 @default.
- W4387015877 hasConceptScore W4387015877C16005928 @default.
- W4387015877 hasConceptScore W4387015877C168563851 @default.
- W4387015877 hasConceptScore W4387015877C2776173921 @default.
- W4387015877 hasConceptScore W4387015877C2777520566 @default.
- W4387015877 hasConceptScore W4387015877C2778329239 @default.
- W4387015877 hasConceptScore W4387015877C2779134260 @default.
- W4387015877 hasConceptScore W4387015877C2779951463 @default.
- W4387015877 hasConceptScore W4387015877C2780699399 @default.
- W4387015877 hasConceptScore W4387015877C71924100 @default.
- W4387015877 hasConceptScore W4387015877C90924648 @default.
- W4387015877 hasIssue "3" @default.
- W4387015877 hasLocation W43870158771 @default.
- W4387015877 hasOpenAccess W4387015877 @default.
- W4387015877 hasPrimaryLocation W43870158771 @default.
- W4387015877 hasRelatedWork W1567707332 @default.
- W4387015877 hasRelatedWork W2003620798 @default.
- W4387015877 hasRelatedWork W2153616910 @default.
- W4387015877 hasRelatedWork W2771084125 @default.
- W4387015877 hasRelatedWork W3158030853 @default.
- W4387015877 hasRelatedWork W3206152140 @default.
- W4387015877 hasRelatedWork W3210501554 @default.
- W4387015877 hasRelatedWork W4225272680 @default.
- W4387015877 hasRelatedWork W4318069789 @default.
- W4387015877 hasRelatedWork W875174592 @default.
- W4387015877 hasVolume "89" @default.
- W4387015877 isParatext "false" @default.
- W4387015877 isRetracted "false" @default.
- W4387015877 workType "article" @default.